| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 0 | 0 | 0 | 40.208 | 51.588 | 117.653 |
| Total Income - EUR | - | - | - | - | 0 | 0 | 0 | 40.459 | 51.619 | 117.781 |
| Total Expenses - EUR | - | - | - | - | 38 | 638 | 475 | 2.862 | 13.605 | 25.199 |
| Gross Profit/Loss - EUR | - | - | - | - | -38 | -638 | -475 | 37.597 | 38.015 | 92.582 |
| Net Profit/Loss - EUR | - | - | - | - | -38 | -638 | -475 | 36.707 | 37.576 | 89.582 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Dacar-Therapy Tm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 121 | 10 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | 94 | 38 | 17 | 56.368 | 38.683 | 126.096 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 23.945 | 21.640 | 114.578 |
| Cash | - | - | - | - | 94 | 38 | 17 | 32.423 | 17.043 | 11.518 |
| Shareholders Funds | - | - | - | - | 4 | -634 | -1.055 | 35.649 | 37.873 | 92.666 |
| Social Capital | - | - | - | - | 42 | 41 | 81 | 81 | 81 | 80 |
| Debts | - | - | - | - | 211 | 682 | 1.071 | 20.718 | 810 | 33.430 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dacar-Therapy Tm S.r.l.